Catalyst Pharmaceuticals (CPRX) Technical (Analysis) Reports Catalyst Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Catalyst Pharmaceuticals (CPRX)
Technical Analysis Report for NASDAQ stock CPRX Catalyst Pharmaceuticals. Dated: 23 Mar 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock CPRX Catalyst Pharmaceuticals then click here. or read Experts views on Catalyst Pharmaceuticals or Forecast & share price targets of Catalyst Pharmaceuticals
Catalyst Pharmaceuticals Opened at 23.06 and Closed at: 23.32, which is 2.32% of previous session's close. It moved within a range of 23.06 and 23.71
The session was a Bullish session with an average volume of 1541600, which is 56.48% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the long term trend of the stock remains negative and in a downtrend.
A Dead cross was found 7 days back on short term averages
A Dead cross was found 3 days back on mid term averages
Support for tomorrow is 23.19 and resistance for tomorrow is 23.84
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 23.02, 22.71 resistance for tomorrow's hourly charts is 23.67, 24.01
10 Day SMA for Catalyst Pharmaceuticals (CPRX) is 23.56 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Catalyst Pharmaceuticals (CPRX) is 23.89 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Catalyst Pharmaceuticals (CPRX) is 23.96 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 23.42 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Catalyst Pharmaceuticals is 22.27 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Catalyst Pharmaceuticals is at 23.89 and 200 DMA is at 22.27, while 50 DMA and 100 DMA are at 23.96 and 23.42 respectively
Catalyst Pharmaceuticals (CPRX) moving average of 20 SMA is at 23.89 and 20 EMA is at 23.68
| Date | Closing Price | 20 SMA | 20 EMA |
| 23 Mon Mar | 23.32 | 23.89 | 23.68 |
| 20 Fri Mar | 22.78 | 23.94 | 23.72 |
| 19 Thu Mar | 22.33 | 24.02 | 23.82 |
| 17 Tue Mar | 23.32 | 24.12 | 23.98 |
| 16 Mon Mar | 23.30 | 24.19 | 24.05 |
| 13 Fri Mar | 23.23 | 24.24 | 24.13 |
Catalyst Pharmaceuticals (CPRX) moving average of 50 SMA is at 23.96 and 50 EMA is at 23.75
| Date | Closing Price | 50 SMA | 50 EMA |
| 23 Mon Mar | 23.32 | 23.96 | 23.75 |
| 20 Fri Mar | 22.78 | 23.94 | 23.77 |
| 19 Thu Mar | 22.33 | 23.94 | 23.81 |
| 17 Tue Mar | 23.32 | 23.95 | 23.87 |
| 16 Mon Mar | 23.30 | 23.94 | 23.89 |
| 13 Fri Mar | 23.23 | 23.93 | 23.91 |
Catalyst Pharmaceuticals (CPRX) moving average of 100 SMA is at 23.42 and 100 EMA is at 23.37
| Date | Closing Price | 100 SMA | 100 EMA |
| 23 Mon Mar | 23.32 | 23.42 | 23.37 |
| 20 Fri Mar | 22.78 | 23.4 | 23.37 |
| 19 Thu Mar | 22.33 | 23.38 | 23.38 |
| 17 Tue Mar | 23.32 | 23.37 | 23.4 |
| 16 Mon Mar | 23.30 | 23.34 | 23.4 |
| 13 Fri Mar | 23.23 | 23.32 | 23.4 |
Catalyst Pharmaceuticals (CPRX) moving average of 200 SMA is at 22.27 and 200 EMA is at 22.77
| Date | Closing Price | 200 SMA | 200 EMA |
| 23 Mon Mar | 23.32 | 22.27 | 22.77 |
| 20 Fri Mar | 22.78 | 22.28 | 22.76 |
| 19 Thu Mar | 22.33 | 22.29 | 22.76 |
| 17 Tue Mar | 23.32 | 22.3 | 22.76 |
| 16 Mon Mar | 23.30 | 22.31 | 22.75 |
| 13 Fri Mar | 23.23 | 22.32 | 22.74 |
Supernus Pharmaceuticals has performed better than Catalyst Pharmaceuticals in short term. You could have earned much better returns by investing in Supernus Pharmaceuticals, about 0.44% more returns!
Catalyst Pharmaceuticals has performed better than Soleno Therapeutics in short term. Holding Catalyst Pharmaceuticals could be a better choice for now!
Catalyst Pharmaceuticals has performed better than Sol Gel in short term. Holding Catalyst Pharmaceuticals could be a better choice for now!
Catalyst Pharmaceuticals has performed better than Si Bone in short term. Holding Catalyst Pharmaceuticals could be a better choice for now!
Catalyst Pharmaceuticals has performed better than Rigel Pharmaceuticals in short term. Holding Catalyst Pharmaceuticals could be a better choice for now!
Catalyst Pharmaceuticals has performed better than Ultragenyx Pharmaceutical in short term. Holding Catalyst Pharmaceuticals could be a better choice for now!
Catalyst Pharmaceuticals has performed better than Ptc Therapeutics in short term. Holding Catalyst Pharmaceuticals could be a better choice for now!
Pulse Biosciences has performed better than Catalyst Pharmaceuticals in short term. You could have earned much better returns by investing in Pulse Biosciences, about 6.95% more returns!
National Research has performed better than Catalyst Pharmaceuticals in short term. You could have earned much better returns by investing in National Research, about 43.36% more returns!
Luminex Corporation has performed better than Catalyst Pharmaceuticals in short term. You could have earned much better returns by investing in Luminex Corporation, about 68.83% more returns!
Catalyst Pharmaceuticals has performed better than Atyr Pharma in short term. Holding Catalyst Pharmaceuticals could be a better choice for now!
Anaptysbio Inc has performed better than Catalyst Pharmaceuticals in short term. You could have earned much better returns by investing in Anaptysbio Inc, about 18.81% more returns!
Ani Pharmaceuticals has performed better than Catalyst Pharmaceuticals in short term. You could have earned much better returns by investing in Ani Pharmaceuticals, about 1.71% more returns!
Catalyst Pharmaceuticals has performed better than Ascendis Pharma in short term. Holding Catalyst Pharmaceuticals could be a better choice for now!
Capricor Therapeutics has performed better than Catalyst Pharmaceuticals in short term. You could have earned much better returns by investing in Capricor Therapeutics, about 11.28% more returns!
Catalyst Pharmaceuticals has performed better than Catalyst Biosciences in short term. Holding Catalyst Pharmaceuticals could be a better choice for now!
Catalyst Pharmaceuticals has performed better than Enanta Pharmaceuticals in short term. Holding Catalyst Pharmaceuticals could be a better choice for now!
Catalyst Pharmaceuticals has performed better than Harrow Health in short term. Holding Catalyst Pharmaceuticals could be a better choice for now!
Iradimed Corporation has performed better than Catalyst Pharmaceuticals in short term. You could have earned much better returns by investing in Iradimed Corporation, about 1.47% more returns!
Catalyst Pharmaceuticals Technical analysis of indicators
Price action analysis of Catalyst Pharmaceuticals (CPRX) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Catalyst Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Catalyst Pharmaceuticals in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Catalyst Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Catalyst Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Catalyst Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 23.67 and Catalyst Pharmaceuticals CPRX stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Catalyst Pharmaceuticals CPRX stock. Volume based technical analysis of Catalyst Pharmaceuticals CPRX stock is negative.
Catalyst Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock CPRX Catalyst Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And CPRX Experts View which covers a lot of information including buying and selling signals
CPRX future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Catalyst Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Catalyst Pharmaceuticals (CPRX) Technical (Analysis) Reports Catalyst Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance


